Related references
Note: Only part of the references are listed.A novel role of IL-17A in contributing to the impaired suppressive function of Tregs in psoriasis
Yanghe Liu et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2021)
The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression
Naoise Mac Giollabhui et al.
MOLECULAR PSYCHIATRY (2021)
Physical and Psychosocial Burden of Psoriatic Arthritis: Longitudinal Data From a Population-Based Study in Norway
Glenn Haugeberg et al.
ARTHRITIS CARE & RESEARCH (2021)
Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2+ and TLR4+ Th17/Tc17-like cells in multiple sclerosis patients with major depression
Marisa C. Sales et al.
IMMUNOLOGY (2021)
Interleukin-17 induced by cumulative mild stress promoted depression-like behaviors in young adult mice
Jinho Kim et al.
MOLECULAR BRAIN (2021)
Two-Year US Pharmacovigilance Report on Brodalumab
Mark Lebwohl et al.
DERMATOLOGY AND THERAPY (2021)
Inflammatory versus Anti-Inflammatory Profiles in Major Depressive Disorders-The Role of IL-17, IL-21, IL-23, IL-35 and Foxp3
Malgorzata Galecka et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Anti-TNF-α Compounds as a Treatment for Depression
Sarit Uzzan et al.
MOLECULES (2021)
Reduced Th1 response is associated with lower glycolytic activity in activated peripheral blood mononuclear cells after metabolic and bariatric surgery
J. R. Villarreal-Calderon et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder
Miguel Angel Alvarez-Mon et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study
Marina Talamonti et al.
ACTA DERMATO-VENEREOLOGICA (2021)
Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk
Ingrid Elisia et al.
PLOS ONE (2020)
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis
Andreas Kerschbaumer et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials
Mark C. Genovese et al.
RHEUMATOLOGY (2020)
Obesity as a risk factor for psoriasis
C. Zachariae et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Deciphering the Association Between Psoriasis and Obesity: Current Evidence and Treatment Considerations
Kyriaki Paroutoglou et al.
CURRENT OBESITY REPORTS (2020)
Depression in Psoriatic Arthritis: Dimensional Aspects and Link with Systemic Inflammation
Ashish J. Mathew et al.
RHEUMATOLOGY AND THERAPY (2020)
Depression and inflammation among children and adolescents: A meta-analysis
Marlena Colasanto et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?
Katarzyna Blizniewska-Kowalska et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia
Milica M. Borovcanin et al.
DIAGNOSTICS (2020)
Autoantibodies against specific nuclear antigens are present in psoriatic disease and are diminished by secukinumab
Eleni Patrikiou et al.
CLINICA CHIMICA ACTA (2020)
Changes in metabolic parameters in psoriatic patients treated with secukinumab
Hsuan Ning Wang et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis
Yufeng Yin et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study
R. Parisi et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Psoriasis: Which therapy for which patient Psoriasis comorbidities and preferred systemic agents
Shivani B. Kaushik et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Psoriasis: Which therapy for which patient Focus on special populations and chronic infections
Shivani B. Kaushik et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
A clinical model for identifying an inflammatory phenotype in mood disorders
Nicole E. Kramer et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
An immune gate of depression - Early neuroimmune development in the formation of the underlying depressive disorder
Malgorzata Kowalczyk et al.
PHARMACOLOGICAL REPORTS (2019)
Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial
Roger S. McIntyre et al.
JAMA PSYCHIATRY (2019)
Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
Lazaros I. Sakkas et al.
FRONTIERS IN PHARMACOLOGY (2019)
Longitudinal association of inflammation with depressive symptoms: A 7-year cross-lagged twin difference study
Minxuan Huang et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders
Lauren M. Osborne et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Th17/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-β) in children with autism spectrum disorder
Mai Moaaz et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Depression and obesity, data from a national administrative database study: Geographic evidence for an epidemiological overlap
Jean-Christophe Chauvet-Gelinier et al.
PLOS ONE (2019)
Proinflammatory IL-17 pathways dominate the architecture of the immunome in pediatric refractory epilepsy
Pavanish Kumar et al.
JCI INSIGHT (2019)
Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities
James G. Krueger et al.
EXPERIMENTAL DERMATOLOGY (2018)
Distinct characteristics of hippocampal pathogenic TH17 cells in a mouse model of depression
Eleonore Beurel et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Th17 cells in depression
Eleonore Beurel et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
COMPARISON OF SERUM CYTOKINE LEVELS IN MEN WHO ARE OBESE OR MEN WHO ARE LEAN: EFFECTS OF NONLINEAR PERIODIZED RESISTANCE TRAINING AND OBESITY
Mahmoud Nikseresht
JOURNAL OF STRENGTH AND CONDITIONING RESEARCH (2018)
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
Mark G. Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
Kim A. Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis
Dimitra Kelepouri et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis
Magdalena Pirowska et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2018)
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Nicolo Costantino Brembilla et al.
FRONTIERS IN IMMUNOLOGY (2018)
Elevated Levels of Serum IL-17A in Community-Dwelling Women with Higher Depressive Symptoms
Hirohito Tsuboi et al.
BEHAVIORAL SCIENCES (2018)
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
J. Koo et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis
J. J. Wu et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders
Patrizia Fasching et al.
MOLECULES (2017)
Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy
Michael Roman et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Animal models to improve our understanding and treatment of suicidal behavior
T. D. Gould et al.
TRANSLATIONAL PSYCHIATRY (2017)
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Emilie Sbidian et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17-and IFNγ-producing T cells
Athanasios Mavropoulos et al.
CLINICAL IMMUNOLOGY (2017)
IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression
Ahmed Nadeem et al.
CYTOKINE (2017)
Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data
Lazaros I. Sakkas et al.
AUTOIMMUNITY REVIEWS (2017)
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Vitamin A supplementation reduces the Th17-Treg - Related cytokines in obese and non-obese women
Mahdieh Abbasalizad Farhangi et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder
Mohammad Hasan Davami et al.
BASIC AND CLINICAL NEUROSCIENCE (2016)
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Christopher E. M. Griffiths et al.
LANCET (2015)
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
M. Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Depression and Anxiety in Psoriatic Disease: Prevalence and Associated Factors
Emily McDonough et al.
JOURNAL OF RHEUMATOLOGY (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of IL-17A blockade with secukinumab in autoimmune diseases
Dhavalkumar D. Patel et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Inflammatory T Helper 17 Cells Promote Depression-like Behavior in Mice
Eleonore Beurel et al.
BIOLOGICAL PSYCHIATRY (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes
S. J. Sukoff Rizzo et al.
TRANSLATIONAL PSYCHIATRY (2012)
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Yihua Cai et al.
IMMUNITY (2011)
Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
H. H. Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Foxp3+Regulatory T Cells of Psoriasis Patients Easily Differentiate into IL-17A-Producing Cells and Are Found in Lesional Skin
H. Jorn Bovenschen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Emerging tendency towards autoimmune process in major depressive patients: A novel insight from Th17 cells
Yili Chen et al.
PSYCHIATRY RESEARCH (2011)
T helper 17 cell heterogeneity and pathogenicity in autoimmune disease
Kamran Ghoreschi et al.
TRENDS IN IMMUNOLOGY (2011)
The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis A Population-Based Cohort Study
Shanu Kohli Kurd et al.
ARCHIVES OF DERMATOLOGY (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Jula Huppert et al.
FASEB JOURNAL (2010)
In Vivo Imaging of Partially Reversible Th17 Cell-Induced Neuronal Dysfunction in the Course of Encephalomyelitis
Volker Siffrin et al.
IMMUNITY (2010)
Altered expression of CD4+CD25+ regulatory T cells and its 5-HT1a receptor in patients with major depression disorder
Yi Li et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
M. Sumarac-Dumanovic et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice
Haruhiko Sugino et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Global burden of obesity in 2005 and projections to 2030
T. Kelly et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells
Ingunn M. Stromnes et al.
NATURE MEDICINE (2008)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
Functional cooperation between interleukin-17 and tumor necrosis factor-α is mediated by CCAAT/enhancer-binding protein family members
MJ Ruddy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
Share Paper
